Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordi Rodon

Showing results (101-110 of 247) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|May 4, 2021
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumoursJordi Rodon, Guillem Argilés, Roisin M Connolly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effectsJaime R Merchan, Jordi Rodon, Shree Venkat, et al.
Emerging Infectious Diseases|February 23, 2023
Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C StrainJordi Rodon, Anna Z Mykytyn, Nigeer Te, et al.
NPJ Precision Oncology|July 7, 2025
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanomaNatalie Y L Ngoi, Ian M Silverman, Adrienne Johnson, et al.
Emerging Infectious Diseases|February 26, 2024
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023Brian Maina Ogoti, Victor Riitho, Johanna Wildemann, et al.
Frontiers in Microbiology|December 2, 2022
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animalsCarla Usai, Lola Pailler-García, Cristina Lorca-Oró, et al.
The Oncologist|March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignanciesJibran Ahmed, Anne Knisely, Carlos Torrado, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumoursLaura Vidal, Ivan Victoria, Lydia Gaba, et al.
Antiviral Research|March 1, 2022
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysisMartin Sachse, Raquel Tenorio, Isabel Fernández de Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, et al.
Pageof 25

Showing results (101-110 of 247) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|May 4, 2021
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumoursJordi Rodon, Guillem Argilés, Roisin M Connolly, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2025
A phase 1B trial of vocimagene amiretrorepvec in patients with advanced solid tumors: Safety, tumor homing, and immune modulatory effectsJaime R Merchan, Jordi Rodon, Shree Venkat, et al.
Emerging Infectious Diseases|February 23, 2023
Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C StrainJordi Rodon, Anna Z Mykytyn, Nigeer Te, et al.
NPJ Precision Oncology|July 7, 2025
Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanomaNatalie Y L Ngoi, Ian M Silverman, Adrienne Johnson, et al.
Emerging Infectious Diseases|February 26, 2024
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022-2023Brian Maina Ogoti, Victor Riitho, Johanna Wildemann, et al.
Frontiers in Microbiology|December 2, 2022
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animalsCarla Usai, Lola Pailler-García, Cristina Lorca-Oró, et al.
The Oncologist|March 26, 2025
A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignanciesJibran Ahmed, Anne Knisely, Carlos Torrado, et al.
European Journal of Cancer (Oxford, England : 1990)|February 15, 2021
A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumoursLaura Vidal, Ivan Victoria, Lydia Gaba, et al.
Antiviral Research|March 1, 2022
Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysisMartin Sachse, Raquel Tenorio, Isabel Fernández de Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2025
Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast CancerMohamed A Gouda, Amrit Gonugunta, Ecaterina E Dumbrava, et al.
Pageof 25